Pexidartinib 125 MG Oral Capsule — RxCUI 2626397
RxNorm drug concept · Semantic clinical drug
RxCUI 2626397
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2626397
Official namePexidartinib 125 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)175 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pexidartinib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Turalio is prescribed for a condition called tenosynovial giant cell tumor, or TGCT — a rare, non-cancerous tumor that grows in the tissue lining joints and tendons. It can cause s...
- What exactly is Turalio used for, and why did my doctor prescribe it?
- Yes, it matters a lot. You need to take Turalio with a low-fat meal — one that has a modest amount of fat. Eating a high-fat meal can dramatically increase how much of the drug get...
- Why do I have to eat something before taking it, and does it matter what I eat?
🕸️ Concept Web — How Pexidartinib 125 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pexidartinib 125 MG Oral Capsule
RxCUI 2626397 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pexidartinib
2183102IN
-
Pexidartinib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Turalio
2183126BN
-
Turalio
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pexidartinib Oral Capsule
2183124SCDF -
Pexidartinib Oral Product
2183122SCDG -
Pexidartinib Pill
2183123SCDG -
Pexidartinib Oral Capsule [Turalio]
2183128SBDF -
Turalio Oral Product
2183129SBDG -
Turalio Pill
2183130SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Pexidartinib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pexidartinib 125 MG
2626396SCDC -
Pexidartinib 125 MG Oral Capsule [Turalio]
2626399SBD -
Pexidartinib 125 MG [Turalio]
2626398SBDC
-
Pexidartinib 125 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pexidartinib 125 MG
SCDC · 2626396 -
Pexidartinib Oral Capsule
SCDF · 2183124 -
Pexidartinib Oral Product
SCDG · 2183122 -
Pexidartinib Pill
SCDG · 2183123
Brand-Name Concepts
-
Pexidartinib 125 MG Oral Capsule [Turalio]
SBD · 2626399 -
Pexidartinib 125 MG [Turalio]
SBDC · 2626398 -
Pexidartinib Oral Capsule [Turalio]
SBDF · 2183128 -
Turalio Oral Product
SBDG · 2183129 -
Turalio Pill
SBDG · 2183130 -
Turalio
BN · 2183126
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2626397 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65597-0407-20 | 1 BOTTLE in 1 CARTON (65597-407-20) / 120 CAPSULE in 1 BOTT... | Turalio | Daiichi Sankyo Inc. | 2023-02-01 |
| 65597-0407-28 | 1 BOTTLE in 1 CARTON (65597-407-28) / 28 CAPSULE in 1 BOTTL... | Turalio | Daiichi Sankyo Inc. | 2023-02-01 |
Observed labelers:
Daiichi Sankyo Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.